Trial
NCT01283178
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
National Cancer Institute (NCI)
Condition
Salivary Gland Squamous Cell Carcinoma
Intervention
intensity-modulated radiation therapy
Why stopped
The study was terminated. The data analysis was futile with only 3 accruals. PI opted to terminate with IRB and withdraw FDA IND.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-31